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ABSTRACT
IDENTIFICATION AND CHARACTERIZATION OF MSAB GENE INVOLVED IN
BIOFILM FORMATION AND VIRULENCE IN STAPHYLOCOCCUS AUREUS
by Amelsaad Elbarasi
August 2014
Staphylococcus aureus is an important human pathogen that causes a wide
variety of life-threatening infections ranging from minor skin and oral infections to
severe infections, such as bacteremia, pneumonia, osteomyelitis, or endocarditis due to
the presence and secretion of a large number of virulence factors that are controlled by
global virulence regulators in complex networks. Furthermore, S. aureus infections have
become a threat to public health because of their high potential to form biofilm, and their
ability to resist a wide range of antibiotics has exacerbated further. Therefore,
understanding the regulatory networks and developing a drug targeting these networks
has the potential to stand as therapeutic targets for future treatment of antibiotic resistant
infections.
In a previous study msaC was identified as the modulator of sarA, a new global
virulence regulator that controls the expression of sarA and biofilm development.
Furthermore, it has also been shown that msaC is a part of four-gene operon, msaABCR
operon, which includes four-genes: SAUSA300_1296 (msaA), SAUSA300_1295 (msaB),
SAUSA300_1294 (msaC), and antisense RNA, msaR. The mechanism of regulation of
msaABCR operon and the function of individual genes were not clearly known yet. This
study defines the role of msaB, the second gene of the msaABCR operon, which will help
shed some light on the regulation of msaABCR. We deleted msaB gene from
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USA300_LAC, and studied the major msaB phenotypes: pigmentation, protease
production, biofilm formation, and rate of cell death. Deletion of msaB resulted in the
similar msaC and/or msaABCR deletion mutant, thus showing the importance of this gene
in this operon. The mutant showed decreased pigmentation, increased extracellular
protease production, decreased biofilm formation, and increased rate of cell death.
Deletion of the msaB gene also resulted in the decreased expression of some key
regulators, like sarA and agr that play major roles in the regulation of virulence and
biofilm formation in S. aureus, similar to msaC and msaABCR operon deletion mutant.
Thus, this study identifies the role of msaB, in the msaABCR operon, that will
help us define the mechanism of regulation of virulence and biofilm formation by the
msaABCR operon and provides a step to investigate the stimulatory signals that the
msaABCR operon responds to during pathogenesis.
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CHAPTER I
INTRODUCTION
Staphylococcus aureus
Staphylococcus was first identified in 1880 in Aberdeen, United Kingdom, by the
surgeon Sir Alexander Ogston in pus from a surgical abscess in a knee joint, and this
name was later appended to staphylococcus aureus (S. aureus) by Rosenbach, who was
credited by the official system of nomenclature at that time. S. aureus is an anaerobic
facultative gram-positive bacterium; it is a member of the Firmicutes, and it’s also known
as golden staph due to its ability to produce a carotenoid pigmentation as is shown in
Figure 1. S. aureus is positive for catalase and nitrate reduction, and this feature
differentiates it from other micrococcaceae like streptococci, and enterococci. It is
estimated that 20% of the human population is a long-term carrier of S. aureus [1] which
can be found as part of the normal skin flora, anterior nares, throat, axilla, perirectal area,
and groin area [1, 2].

Figure 1. Staphylococcus aureus has been grown on TSA (Tryptic Soy Agar) media. The
strain is producing a yellow pigmentation (Golden Staph).
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Although S. aureus is not always pathogenic, it may cause a wide variety of lifethreatening infections when it enters in the human body; its ability to acquire resistance to
antibiotics very rapidly and its ability to form biofilm to cause biofilm-associated
infection is very alarming. S. aureus is an important human pathogen associated with one
of the most common cause of healthcare and community-associated infections [3]. Even
though, it has been over 100 years since the discovery of S. aureus, the mode of action is
still controversial and it has to be fully elucidated. Since human are considered a natural
reservoir of S. aureus, it is estimated that around 30 to 50 percent of the human
population is persistently colonized with both methicillin-sensitive and methicillinresistant isolates [4, 5].
The frequencies of both community-acquired and hospital-acquired
staphylococcal infections have increased steadily over the past 20 years, with little
change in overall mortality [6], and during the period from 1990 through 1992, S. aureus
was the most common causes of nosocomial infection according to data from the
National Nosocomial Infections Surveillance system of the Centers for Disease Control
and Prevention (CDC), and they spread rapidly to populate many hospitals and diverse
geographic regions with unique processes and yet undefined pathogenicity [7, 8].
Impact of S. aureus on Oral Cavity
The oral cavity acts as a reservoir for many pathogens that may cause local or
systemic infections [9]; for instance, saliva and the periodontal pocket serve as an
ecological niche appropriate for hosting microorganisms that could act as opportunistic
pathogens. There are over 700 different bacterial species in the oral microflora [10], and
those species have the ability to colonize the whole mouth such as oral mucosa, hard
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palate, tongue, teeth, carious lesions, and periodontal pocket. The distribution of
microflora in the oral cavity is not random, most species prefer certain sites over others
due to the particular local environment those sites provide [11]. Cuesta Al et al. 2010 [12]
showed that the oral cavity and sub-gingival pocket are ecological niches for
microorganisms that may act as opportunistic pathogens, such as S. aureus and especially
methicillin-resistant S. aureus (MRSA) is one of them. Early detection of MRSA is a
matter of concern to Public Health that can help prevent further infections.
Passariello et al. 2012 [13] also found that the oral cavity is an important site of
S. aureus colonization and showed that conditions modifying the oral environment, such
as the presence of periodontitis and fixed prosthetic restorations, promote S. aureus and
may favor the spread of more pathogenic strains. Information regarding the risk of
methicillin-resistant Staphylococcus aureus (MRSA) infection transmission in dental
healthcare settings was incomplete only a few years ago; therefore, MRSA infection
control guidelines were necessarily based on data extrapolated from other fields. Recent
publications have made it possible to review such risk. The relationship among these
pathogens, periodontal bacteria, and periodontal clinical status is poorly understood.
S. aureus colonizes and causes infection of the oral cavity and this is an
important aspect in its pathogenesis because it has been isolated from a wide variety of
oral infective conditions, as angular parotitis and cheilitis [14]. Recently, staphylococcal
infection has been shown in a clinical condition, which classified as staphylococcal
mucositis, emerging as a clinical problem in many debilitated old patients and those
suffering from oral Crohn's disease [15]. Also, higher caries rates of Coagulase negative
staphylococci and S. aureus, or both, appear in patients and have the ability to develop
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joint infections, which raises the possibility of the oral cavity serving as a potential
source for spread of bacteremia to compromised joint spaces [16].
Furthermore, Staphylococci isolated from sub-gingival samples of patients with
advanced periodontitis were tested for leukocidal activity. Intact organisms, bacterial
sonicator, or bacterial culture supernatants were incubated with human neutrophils that
had been pre-labeled with 51chromium. The most common of S. aureus periodontal
isolates provoked dose-dependent extracellular release of the radiolabel. By contrast,
other strains of staphylococci had marginal or no demonstrable leukocidal activity.
Leukocidal activity was heat-sensitive and was neutralized by horse anti-leukocidin
antibodies. The results indicate that S. aureus colonizing human periodontal lesions
elaborate a leukocidin that may conceivably destroy neutrophils that immigrate into the
gingival region. This could adversely affect the overall status of this antimicrobial
defense system in the gingival area and contribute to the pathogenicity of S. aureus as
well as other potential periodontopathic organisms [17].
Biofilms in the Oral Cavity
Accumulation of bacterial biofilm (plaques) on tooth surfaces results in some of
the most prevalent bacterial-induced diseases of man—caries and inflammatory
periodontal diseases [18]. The former is due to the accumulation of the biofilm
supragingivally and involves dissolution of enamel and dentine. The latter stem from a
build-up of plaque at and below the gingival margin and the irreversible phase of the
disease, chronic periodontitis, that is characterized by detachment of the gingiva from the
root surface of the tooth, resulting in a periodontal pocket and, ultimately, resorption of
the alevolar bone occurs and leads to tooth loss. There are several other studies conducted
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to solve the puzzle of staphylococci pathogenesis in the oral cavity but it still remains
unclear and requires more research in this area.
The S. aureus Virulence and Biofilm Development
The ability of S. aureus to infect a variety of tissues in the human body is due to
its expression of a wide variety of virulence factors such as surface-associated proteins,
secreted proteases, toxins, and immune modulators [19]. Expression of these virulence
factors in is carefully coordinated by a variety of regulators that include trans-acting
global regulators, alternative sigma factors, and small non-coding RNAs [20]. The
community-acquired methicillin-resistant S. aureus (CA-MRSA) strains often cause
localized infections by producing various enzymes, such as protease, lipase, and
hyaluronidase, that destroy the tissues in immune-compromised hosts. These strains show
enhanced virulence leading to severe infections among healthy individuals without any
predisposing risk factors; however, their role in the pathogenesis of disease is still not
well understood.
One of the major factors responsible for the establishment of chronic infection by
S. aureus is its ability to form biofilm virtually on any host surfaces [21]. S. aureus can
form biofilms on host surfaces like heart valves, bone [22], cartilage, and medical
implants like catheters and orthopedic devices [23, 24].
A biofilm is an aggregation of any group of microorganisms, in which the cells
stick to each other and upon a solid surface, typically with a fluid of microbes bathing
[25]. Biofilms can be found everywhere on living or non-living surfaces and can be
prevalent in natural, industrial, and hospital settings. The main components of mature
biofilm are approximately 5-25% bacterial cells and 75-95% glycocalyx matrix [26].
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These adherent cells are frequently embedded within a self-produced matrix of
extracellular polymeric substance (EPS). Biofilm EPS, which is also referred to as slime
(although not everything described as slime is a biofilm), is a polymeric conglomeration
generally composed of extracellular DNA, polysaccharide and proteins. These microbial
communities form micro-colonies that interact with each other using very sophisticated
communication methods (i.e., quorum-sensing) [27]. The development of unique
microbiological tools to detect and assess the various biofilms around us is a
tremendously important focus of research in many laboratories.
The S. aureus biofilm forms in three distinct stages as shown in Figure 2:
1. The free-floating cells attach to the surfaces by means of adhesions or cell wall
components, which also help other microorganisms to attach to the surface because they
cannot do it on their own.
2. Accumulation of the multilayered cells via subdivision, and then they start production
of their self-polysaccharide matrix, which help maturation of the biofilm.
3. Detachment of biofilm cells and dispersal to new distant sites for colonization or to
infect other areas, and this is the most important stage in the biofilm life cycle.

	
  

7	
  

Figure 2. Schematic represents stages of biofilm formation.
This fully matured stage is characterized by an overall shift in gene expression
patterns total different from the planktonic stages and offering increased resistance to
antimicrobials. Once they are fully developed biofilm, via production of some biofilm
destabilizing proteins like phenol soluble modulins (psms), disassembly of biofilm occurs
resulting in free-floating planktonic cells (dispersion) that are able to re-initiate the
biofilm development process in another site [28]. Several factors like extracellular
matrix, reduced metabolic state of bacteria within the biofilm, and efficient spread of
antibiotic resistance mechanisms via gene transfer within the biofilm community
contribute to the biofilm recalcitrance [29].
Global Regulators in S. aureus
The S. aureus genome has 124 putative transcriptional regulators [30], and several
global regulators have been identified, which include the agrA operon, the sarA gene
family, the saePQRS operon, and the genes arlRS, lytSR, srrAb, hssRS, vraSR, and graSR
[31, 32]. Several other regulators have also been identified, though they are not as well
characterized (e.g., htrA, ccpA, msrR, and svrR) [33].
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The first and most important globular regulator gene in S. aureus genome is
Staphylococcal accessory regulator A (SarA); its family of homologs is transcriptional
regulators that control the expression of several genes [34], including virulence factors,
and biofilm formation. The sarA locus comprises three promoters (P1, P2, and P3) that
drive expression of three transcripts, sarB, sarC, and sarA, respectively; however, the
mechanism of regulation of sarA is not fully understood [35]. Indeed, the environmental
signals that modulate the expression of SarA or its activity are not known either.
Inactivation of sarA leads to a reduction in biofilm formation [36], and it is epistatic to
agr (accessory gene regulator ) during biofilm formation [37, 38]. SarA mutants are
deficient in biofilm formation and show reduced expression of the icaADBC operon,
increased protease and nuclease activity, and degradation of surface-associated proteins
like FnbA, FnbB, and spa [36, 39, 40].
The next globular regulator, accessory gene regulator (agr) is also a global
regulator that encodes a quorum-sensing system in S. aureus, and the main effector
molecule of agr is RNAIII, which is expressed in temporal fashion, reaching a maximum
in the transition from the post-exponential to the stationary growth phase. Repression of
agr is also important for biofilm formation [41].
The agr system regulates a large number of virulence factors, especially
exoprotein genes like hla, hlb, hld, hlCB, sspABC, splABDF, aur, and many others,
whereas it decreases the expression of several cell wall-associated protein genes like
fnbA, fnbB, spa, and coa [42].
The other important global regulator is the alternate sigma factor B (sigB), which
responds to environmental stress during stationary growth phases [43, 44]. The sigB gene
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regulates its targets via other regulatory genes or by acting directly on the promoters of
virulence genes. Although sigB positively regulates expression of sarC and negatively
regulates agr, its effect on sarA is not yet known [45, 46]. It seems that sigB acts in
opposition to RNAIII, as most of the exoenzymes and toxins were negatively influenced
by sigB, while the expression of several adhesions was increased [47].
We recently identified a new global regulator named msaABCR operon,
modulator sarA that plays a role in autolysis, biofilm formation, and virulence in the
clinical isolate of community acquired S. aureus strain USA300_LAC [48]. In addition,
it also regulates the expression of some other well studied global regulators including
sarA, agr, and sigB, which plays a role in pathogenesis. So understanding virulence
regulation during growth under different environmental conditions (e.g., biofilm
development) is imperative for the effective prevention and treatment of S. aureus
infections.
In this study, we deleted the second gene of msaABCR operon, msaB gene, by an
allelic gene replacement method and studied the phenotypes of msaB gene and compared
with the msaC and msaABCR deletion mutant in order to elucidate the role of this gene in
the operon.
Although it was not clear if msaB gene regulated virulence genes directly via its
effect on global regulators (SarA and agr genes) or if it has a different pathway, we did
not discover it yet in this experiment. Since sarA has been shown to be essential for
biofilm development in several strains [36], it is not clear if the msaB defect is due to the
reduction in sarA or other factors.
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Sequence analysis of the msaB gene showed it is conserved among S. aureus
strains and encodes a protein that is a cold shock domain, which is a member of a family
of small cold-shock proteins (CSPs) that are induced during bacterial cell response to
stress like low temperatures. Bioinformatics analysis also showed that this protein
preferentially binds single-strand RNA and DNA and appears to play an important role in
cell physiology under both normal and cold-shock conditions. Although, the function of
CSPs in cold-shock adaption has not yet been elucidated in detail, a number of
experimental evidence suggests that CSPs bind messenger RNA (mRNA) and regulates
ribosomal translation, the rate of m-RNA degradation, and the termination of
transcription [49]. Interestingly, the cold shock protein family has shown structural
similarity in different bacterial species (for instance, E.coli, Mycobacterium tuberculosis,
Streptococcus pyogenes, Pseudomonas aeruginosa, Yersinia pestis, and Haemophilus
influenzae) and in other important species such as human, Caldosporium herbarum, and
C.elegans [50].
The Goals of This Project
Our previous study showed that msaABCR is an operon that contains three noncoding RNAs, msaA, msaC, and msaR, and it interacts with other global regulators like
sarA, agr, and sigB; however, the mechanism of regulation and role of each gene in the
operon has been studied. In this study we elucidate the role of msaB in the msaABCR
operon to regulate the virulence and biofilm formation in S. aureus.
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CHAPTER II
CHARACTERIZATION OF MSAB GENE
Abstract
Staphylococcus aureus is an important human pathogen that causes a wide variety
of infections because S. aureus produces a vast array of virulence factors that are
controlled by global virulence regulators. Previously identified msaABCR is a new global
virulence regulator that controls the expression of sarA, agr, and sigB and virulence and
biofilm development in S. aureus [48].. To define the role of individual genes in the
operon, we deleted msaB gene from USA300_LAC strain and compared its phenotype to
single msaC mutant and msaABCDR operon deletion mutant.
Our preliminary data showed that the studied phenotypes of msaB deletion
mutants are similar to both msaC and msaABCDR operon deletion mutants, and showed
decreased pigmentation, increased extracellular protease activity, increased cell death,
and reduced biofilm formation. The whole msaABCR operon gene is required for the full
complementation of msaB gene, which also supports our previous findings that all genes
in an operon in cis are required for the function of this operon. Defining the mechanism
of action of the msaABCDR operon locus, its role in virulence and biofilm development
will build more information for understanding S. aureus network virulence in order to
combat their outbreak in the near future.
Introduction
The S. aureus causes life-threatening infections because it produces large
numbers of virulence factors and posses complex regulatory networks that control these
virulence factors [51]. S. aureus infections have become a threat to public health due to
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its ability to resist a wide range of antibiotics. Therefore, understanding the function of
complex regulatory networks that regulate the virulence factors and pathogenicity of S.
aureus is important to develop potential future therapeutic targets against these
pathogens, which are very inflexible against antibiotic treatment [52]. Some of the
important global regulators of virulence in S. aureus are msaABCR, sarA, sigB, and agr.
We have previously shown that msaABCR operon positively regulates the expression of
some global regulators like sarA, agr, and sigB, which they are very well studied global
regulators that globally regulate virulence and biofilm development in S. aureus. In this
study, we studied the role the second gene of msaABCR operon, msaB gene, in order to
elucidate the role of this gene in the operon.
Materials and Methods
The Bacterial Strains and Plasmids
All strains and plasmids used in this study are listed in Table 1 below. The S.
aureus strains (community-acquired MRSA strain USA300_LAC, restriction-deficient
laboratory strain RN4220), E. coli strain DH5α, pJB38 gram positive shuttle vector, and
pCN34 low copy plasmid vector were used in this study. The S. aureus strains were
grown in tryptic soy broth (TSB) medium. Antibiotics (chloramphenicol (10 µg/ml),
erythromycin (10 µg/ml), and kanamycin (50 µg/ml) were used in TSB or TSA where
needed. Similarly, E. coli strains were grown in LB broth with ampicillin (100 µg/ml)
added where needed.
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Table 1
Bacteria Strains and Plasmids Used in This Study

Plasmids

	
  

Plasmid

Relevant Characteristics

Source

pJB38

Gram positive shuttle vector

NARSA

pCN34

pT181-based low copy number E. coliStaphylococcal shuttle vector

NARSA

pMOE
526

pJB38-ΔmsaB vector plasmid in Ecoli

This study

pMOE 528

pJB38-ΔmsaB vector plasmid in RN4220

This study

pMOE 586

pCN34-msaB gene in Ecoli .::msaBgene
complement

This study

pMOE 595

pCN34-msaB gene in RN4220.::msaBgene
complement

This study

14	
  
Table 1 (continued).

Strains

Strains

Relevant characteristics

Reference or
source

RN4220

Restriction deficient mutant of 8325-4

NARSA
Dr. Lindsey
Shaw

LAC

CA-MRSA USA300 strains

This study

MOE 531

LAC:: Δ msaA deletion mutant

This study

MOE 596

MsaB gene complement into msaA deletion
mutant

This study

Construction of msaB Deletion Mutant and its Complementation
The upstream and downstream flanking regions of msaB gene were amplified by
using high fidelity PCR reaction using primers MsaB_upstr_F/R and MsaB_dnstr_F/R
respectively (All primers used in this study are listed in Table 2 below). The upstream
and down-stream PCR products were digested with bamHI and ligated to amplify the
ligated PCR product using the terminal primers MsaB_upstr_F and MsaB_dnstr_R. The
amplified ligated PCR product and pJB38 plasmid vectors were again digested with knpI
and salI, purified, and then ligated to construct the deletion plasmid construct
pJB38_msaB. The plasmid pJB38 is an allelic replacement vector, which is a temperature
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sensitive shuttle vector was used to successfully delete other S. aureus genes; one of the
special features of pJB38 is that it offers an inducible counter selection with
anhyrotetracycline (aTc) that selects for chromosomal excision and loss of plasmid
without the use of an antibiotic. The pJB38_msaB deletion plasmid construct was
transduced in wild type S. aureus strain USA300_LAC, and deletion procedures were
followed as described in Sahukhal and Elasri, 2014 [48].
The msaB complement was constructed by amplifying the wild type msaB gene
from wild type LAC strains with complmsaB F/R primers, that contain restriction site
BamHI and EcoRI, respectively. The amplified msaB gene and gram-positive low copy
number shuttle vector, pCN34, was digested with BamHI and EcoRI, and ligated with the
amplified msaB gene. The pCN34 vector containing msaB gene (pCN34-msaB) was then
inserted into RN4220 by electro-transformation. The transformants containing pCN34msaB were confirmed by restriction digestion and sequencing. Finally, pCN34-msaB
gene was transduced into an msaB deletion construct and was used as the complement
strain for the study.
Table 2
The Primers Used in This Study

Primer for msaB deletion and msaB complement

	
  

MsaB upstr F

GGGGACAAGTTTGTACAA
AAAAGCAGGCTGCTTTAAATCAGCGATTAATGTTCG
TTTG

MsaB upstr R

AACGTTGTTAAAGGATCCTTCTTAGATTTGAATCAT
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Table 2 (continued).

MsaB dnstr F

CCTTGTTTCAGGATCCGAAACCTCCAAGACTAAAAT
TCAT

MsaB dnstr R

GGGGACCACTTTGTACAAGAAAGCTGGGTAGTTTGG
ATTTATCAATTCAATATGGCTTAGC

MsaB compl F

AGGATCTGCAGATATTTTATAGTTTCATTG

MsaB compl R

ACCTCGTCGTTGGGATCCATA

RNA Isolation and Real-Time qPCR
The total RNA was harvested and the Real-time PCR was performed as
previously described in Sahukhal and Elasri, 2014 [48]. In brief, overnight cultures of S.
aureus were diluted to an OD600 of 0.05 in TSB and incubated at 37°C with shaking (200
rpm) until they reached an OD600 of 4.0, and RNA was harvested using RNeasy mini kit.
The quality of the total RNA was determined by Nano-drop and a Bioanalyzer (Agilent),
and Real time PCR was performed. The constitutively expressed gyrase A (gyrA) gene
has been used as an endogenous control gene and has been included in all experiments.
Analysis of expression of each gene has been done based on at least three
individual experiments, and two-fold or higher changes in gene expression have been
considered significant. All the primers used for RT-qPCR are listed in Table 3 below.
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Table 3
Primers Used in RT-qPCR

Primers used in RT-qPCR analysis

RT msaB F

TTTATCGAAGTTGAAGGAGAAAATG

RT msaB R

ACTCAACAGCTTGACCTTCTTCTAA

RT sarA F

TTTGCTTCAGTGATTCGTTTATTTACTC

RT sarA R

GTAATGAGCATGATGAAAGAACTGTATT

RT agrA F

TTTGTCGTCAATCGCCATAA

RT agrA R

TTTAACGTTTCTCACCGATGC

RT gyrA F

GCTCGTTCGTGACAAGAAAA

RT gyrA R

TTTGCATCCTTACGCACATC

Phenotypic Assays
1. Triton X-100 induced autolysis. Autolysis assay was performed using Triton
X-100 as described by Manna et al. 1997 [53]. Overnight bacterial cultures were diluted
to an OD 600 of 0.05 in TSB broth contain 1M NaCl. The bacteria were grown until the
optical density A580 0.7. The cells were collected by centrifuging at 10,000 rpm for 10
min at 4˚C, and then the cells were washed twice with ice-cold autoclaved water and then
were suspended in autolysis buffer (50 mM Tris-HCl (pH 7.5) containing 0.1% (v/v)
Triton-x-100). The rate of autolysis was measured at A580 every 30 min intervals for 3
hrs.

	
  

18	
  
2. Pigmentation assay. A pigmentation assay was performed on cells harvested
from overnight cultures, as described by Morikawa et al. 2001 [54]. Briefly, 1 ml of the
over-nightly grown cells were harvested and washed twice with water. They were then
suspended in 1 ml of methanol and heated at 55°C for 3–5 min with occasional vortexing.
The cells were removed by centrifugation at 15,000-x g for 1 min, and the absorbance of
the supernatant was measured at 465 nm with water as a blank. Mean values from a
minimum of three independent experiments, each performed in triplicate, were recorded.
3. Protease assay. Protease activity assay was performed as described by
Sambanthamoorthy et al. 2006 [55]. In brief, 300 µl of the culture supernatant from
overnight cultures were mixed with 800 µl of 3 mg azocasein ml−1 in Tris-buffered saline
(pH 7.5) and incubated overnight at 37°C in dark. After incubation un-degraded
azocasein was precipitated by adding 400 µl of 50% (w/v) trichloroacetic acid, removed
by centrifugation, and the amount of acid-soluble azocasein was determined by
measuring at 340 nm using water as blank. We took the mean values from a minimum of
three independent experiments, each performed in triplicate, and recorded.
4. Microtiter plate Biofilm assay. The microtiter biofilm assay was performed as
described in Sambanthamoorthy et al. 2008 [56] but with slight modification. Briefly,
overnight cultures of cells, including wild type, mutant, and the complemented strain of
USA300 LAC were diluted 1:100 times in TSB supplemented with 3% NaCl and 0.25%
glucose and inoculated in microtiter plates pre-coated with 20% human plasma. Cultures
were incubated for 24 or 48 hrs with shaking at 150 rpm. The adherent biofilm was
quantitated at 615 nm after washing and staining with crystal violet and elution with 5%
acetic acid. Absorbance readings were made at 615 nm using a SpectraMax M5
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microplate spectrophotometer system. Experiments were performed in triplicate and three
independent experiments were performed for each of this assay.
Confocal Microscopy of Biofilm
For confocal microscopy assay of biofilm produced by the msaB deletion mutant,
the biofilms were grown on microtiter as described above. The 48 hrs biofilm was stained
with live-dead cell stains Syto-9 [1.3 µm] and Toto-3 [2.0 µm] respectively. The stains
were prepared in 2 ml of filter-sterilized PBS buffer prior to be used for staining. The Zstack images of the biofilm were taken under 60X objective with oil immersion. The
Syto-9-dye (Green fluorescence) was excited with an argon laser at 488 nm, and the
emission band-pass filter used for Syto-9 was 515 ± 15 nm, and was used to stain the live
cells in the biofilm. The Toto-3-dye (Red fluorescence) was excited using a HeNe 633nm laser, and emissions were detected using a 680 ± 30-nm filter, and was using to stain
the dead cells and eDNA, then incubated at 30oC in dark for 10 minutes. The images
obtained by CLSM were analyzed using the COMSTAT program where the total biomass
of the biofilms, thickness of the biofilm, and amount of live and dead cells within the
biofilm were quantified.
Effect of Different Environmental Conditions on Static Biofilm Formation by msaB
Mutant
To study the effect of different environmental conditions that affect biofilm, the
static microtiter biofilm was grown as described above, but in the presence of different
concentrations of NaCl, glucose, and ethanol tested. To test the different concentrations
of NaCl, the TSB with 0.5% glucose concentration supplemented with sodium chloride at
concentrations ranging from 0 to 6%, were used.
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To test the different concentrations of glucose, the TSB with 3% NaCl
supplemented with glucose at concentrations ranging from 0 to 5% was used. Similarly,
to test the effect of different concentrations of ethanol, TSB with 3% NaCl, supplemented
with ethanol at concentrations 0.5% to 6%, and TSB with 0.5% Glucose, supplemented
with ethanol at concentrations 0.5% to 6%, were used. The biofilms were grown in
presence of different concentrations of NaCl, glucose, and ethanol, as mentioned earlier
in separate microtiter plate, incubated for 48 hrs, washed three times and quantified as
described above.
Biofilm Detachment Assays
We studied the effect of different chemicals and media that affects the biofilm
stability. To determine the sensitivity of biofilms to Sodium metaperiodate, DNase I,
proteinase K, the biofilm was grown in human plasma coated microtiter plate as
described above for 48 hrs and treated them as previously described in Rice et al. 2007
[57]. Briefly, the biofilm was grown in biofilm media and incubated at 37°C with shaking
at 150 rpm each for every chemical tested. Sodium metaperiodate (10mM), DNase I
(10U/ml), and Proteinase K (100ug/ml) were introduced at different point time intervals
(0 to 12 hrs) in their respectively labeled plates and further incubated till 48 hrs. After
incubation, the wells were rinsed gently with 200 ul of PBS three times, air dried, fixed
with 100 ul of absolute ethanol, and stained with 0.2% crystal violet for 10 min. The
absorbance was then measured at 595 nm to quantify the remaining biofilm.
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Results
Construction of msaB Deletion Mutation in CA-MRSA strain USA300_LAC
We amplified the upstream and downstream flanking region of msaB gene and
inserted them into a deletion vector pJB38, to construct the deletion plasmid, pJB38msaB. Once we transduced the deletion plasmid into wild type LAC strain, we performed
the deletion steps as described in the Material and Methods section. We screened and
confirmed the msaB deletion from LAC by using PCR (Figure 3) and sequencing of the
PCR product. We then introduced msaB gene (pCN34-msaB) into msaB deletion mutant
and used it as the complement construct for further study and we verified the msaB
mutant complement construct by both sequencing of the PCR product and by using
restriction digestion of two restriction enzymes, which are Bam HI and EcoRI, as show in
Figure 4.

Figure 3. Gel electrophoresis shows poly chain reaction (PCR) using terminal primers to
verify msaB deletion mutant construct in USA300_LAC wild type (the construct size
around1.5kb).
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Figure 4. Gel electrophoresis shows restriction digestion to verify the presence of msaB
complement construct in pCN34-msaB complement construct by using two restriction
enzymes, Bam HI and EcorI. Upper bands refer to pCN34 plasmid (Vector), which size
around 7 KB, and lower bands refer to msaB complement construct (Insert), which size
around 1.5 KB.
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Figure 5. Shows the msaABCR operon map, which include of the msaA, msaB, msaC,
and msaR genes (short thick grey arrows). Also it shows different alternative forms of the
RNA transcripts (long thin black arrows) formed by the msaABCR operon [48].
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Relative Expression of Global Regulators sarA and agr
We measured the expression of global regulators sarA and agr by RT-qPCR in
the msaB deletion mutant. We observed decrease in expression of sarA and agr (Table 4),
similar to msaC and msaABCR operon deletion mutant [48].
Table 4
Relative Expression of the Global Regulator, SarA, and Agr in the MsaB mutant and its
Complement Relative to Wild Type (USA300_LAC)

Genes

MsaB deletion mutation

MsaB complement

MsaB

-16.767

-2.23

SarA

-2.14

137.18

Agr

-2.29

-2.24

Note: The fold change transcription level in various strains relative to wild-type USA300_ LAC, and the values represent the mean
ratio of three independent experiments.

Phenotypic Characterization of msaB Deletion Mutant
We studied several phenotypes in the msaB deletion mutant and compared with its
wild type and complement. The msaB deletion mutant showed a significant defect in
biofilm formation, pigmentation, and showed increased protease production, as well as
increased rate of cell death (Figures 6, 7, 8, & 9). The phenotypes we observed were
similar to the msaC deletion and msaABCR operon deletion mutant. This supports the
previous result that msaB is an important part of msaABCR operon. Reintroduction of
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msaB cloned in the low copy plasmid pCN34 into the deletion mutants led to an
increased biofilm formation, increased pigmentation, decreased protease, and decreased
cell autolysis, confirming that all the phenotypic characteristics we saw were due to
deletion of the msaB gene.
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Figure 6. Phenotypic characterization of msaB deletion mutant and msaB mutant
complement. Comparison of the msaB deletion mutants relative to complement mutant
and wild type USA300_LAC. Phenotypic assay was done on Triton X-100 induced lytic
assay. Values represent the average of three independent assays, each of which was done
in triplicates. Results are reported as the mean ± S.E, and the standardized errors are
represented as error bars.
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Figure 7. Phenotypic characterization of msaB deletion mutant and msaB mutant
complement. Comparison of the msaB deletion mutants relative to complement mutant
and wild type USA300_LAC. Phenotypic assay was done on pigmentation, and values
represent the average of three independent assays, which were done in triplicates. Results
are reported as the mean ± S.E, and the standardized errors are represented as error bars.
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Figure 8. Phenotypic characterization of msaB deletion mutant and msaB mutant
complement. Comparison of the msaB deletion mutants relative to complement mutant
and wild type USA300_LAC. Phenotypic assay was done on extracellular protease
activity, and values represent the average of three independent assays, which were done
in triplicates. Results are reported as the mean ± S.E, and the standardized errors are
represented as error bars.
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Figure 9. Phenotypic characterization of msaB deletion mutant and msaB mutant
complement. Comparison of the msaB deletion mutants relative to complement mutant
and wild type USA300_LAC. Phenotypic assay was done on biofilm formation, and
values represent the average of three independent assays, which were done in triplicates.
Results are reported as the mean ± S.E, and the standardized errors are represented as
error bars.

Figure 10. Biofilm formation in msaB mutant in microtiter plates. The wild type strain
LAC (First row), the msaB mutant strain (Second row), and the complement msaB
mutant strain (Third row) were grown in TSB supplement with 3% NaCl and 0.5%
glucose, cultures were incubated for 48 hrs in the wells of microtiter plates with precoating with plasma proteins. The violet staining is an indication of biofilm formation in
the wells.
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Confocal Microscopy of Biofilm
We further analyzed the biofilm formation by the msaB deletion mutant by
confocal microscopy after staining with live/dead staining with syto-9 and toto-3 and
compared with WT LAC and its complement. We observed that msaB mutant biofilm is
unable to form mature peculiar tower-like structure (white arrow head) and more
aggregation of cells death compared to the LAC and complement (Figure 11). This
suggests that increased cell death might be responsible for the biofilm defect in the msaB
mutant, while the importance of other factors still needs to be tested.

A.

B.
LAC (Wild type)

C.
msaB mutant

msaB complement

Figure 11. Confocal microscopy (Z-stack images) of static biofilm on microtiter plate.
(A) LAC wild type, (B) msaB mutant, and (C) Complement msaB mutant were grown up
to 48 hours and stained with Syto-8dye stain (staining live cells with green fluorescence
stain) and Toto-3dye stain (staining dead cells and eDNA with red fluorescence stain).
They stained under 40X /1.4 Oil DIC objectives, and these images are representative of
three independent experiments with similar results with scale bar represents 10 µm.
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COMSTAT Analysis of Confocal Microscopy of MsaB Deletion Mutant Biofilm
We performed COMSTAT analysis for the biofilm formation by the msaB
deletion mutant and compared with the wild type and its complement. The analysis
showed the presence of significantly less live cell biomass by the mutant, 40% compared
to 100% by the wild type. The complement produced the cell biomass intermediate
between the wild type and complement. Moreover, the mutant showed the presence of
increased cell death (169%) compared to wild type (100%). This analysis suggests that
increased number of cell death might be responsible for the defective biofilm formation
by the msaB mutant. Further analysis by the COMSTAT also revealed that the mutant has
significantly reduced biofilm thickness (12 µm) compared to wild type (24 um). All the
results are shown in Figure 12.
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Figure 12. COMSTAT analysis of (A) Live cells, which appear as green columns (B),
Dead cells, which appear as red columns, and (C) Biofilm thickness (appear as blue
columns) of confocal microscopy of msaB deletion mutant biofilm.
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Effect of Different Environmental Conditions on msaB Biofilm
We examined different environmental conditions that effect biofilm formation on
msaB mutant and compared them with msaB complement and the wild type
USA300_LAC. We first examined the effects of osmotic stress (NaCl), which was found
to induce biofilm formation in biofilm positive strains when grown under stress-induced
conditions [58]. So in order to test whether msaB gene was involved in transduction of
the osmolarity signal for biofilm formation, we assayed biofilm formation by wild type
(LAC), msaB and complement msaB in the presence of different NaCl concentrations.
We found no significant difference in the biofilm formation by the msaB mutant in any of
the concentration of NaCl tested compared to its wild type and complement (Figure 13).
Furthermore, we also tested the effect of ethanol in combination with either NaCl or
Glucose in TSB. As shown in Figure 10, the biofilm produced by the msaB deletion
mutant is not significantly different when grown in TSB/ethanol (Figure 14 A) and
TSB/ethanol/NaCl (Figure 14 C); however, interestingly msaB deletion mutant produced
significantly increased biofilm in TSB/ethanol/glucose (Figure 14 B). We still need
further investigation of why msaB mutant produces more biofilm in TSB/ethanol/glucose.
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Figure 13. Effect of different sodium chloride concentration, 0%, 0.5%, 1%, 2%, 3%,
4%, 5%, 6%, on biofilm development in msaB mutant strains compared with wild type
(LAC) and its msaB complement; the standardized errors are represented as error bars.
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Figure 14. Effect of ethanol on biofilm formation, (A) shows different ethanol
concentration, (B) shows different ethanol concentration with constant of 0.5% glucose
concentration, and (C) shows different ethanol concentration with constant of 3% sodium
chloride concentration, in msaB mutant strain, msaB complement in comparison to the
USA300_LAC wild type.
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Glucose has been shown to induce the multicellular aggregation step of biofilm
formation, increases PIA production [59], and thus induces biofilm formation. We
studied the effect of different glucose concentrations (0 to 4%) in the biofilm formation
by msaB mutant. We observed defective biofilm formation by the msaB deletion mutant
at low concentration of glucose. But as the concentration of glucose increased from 1%
onwards, msaB restored the biofilm formation back to wild type level. We still need
further explanation of and research on why msaB biofilm defect is glucose dependent,
whereas the wild type and complement does not respond much to the change in glucose
concentration (Figure 15).
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Figure 15. Effect of different glucose concentration, 0%, 0.2%, 0.5%, 1%, 2%, 3%, 4%,
& 5%, on biofilm development in msaB mutant strain (Red column), msaB complement
(Green column), and LAC wild type (Blue column); the standardized errors are
represented as error bars.
Biofilm Detachment Assay Results
Sodium-metaperiodate (NaMP) affects the production of Poly-N-acetyl
glucosamine (PNAG) also known as Polysaccharide intracellular adhesion (PIA). If
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biofilm is disrupted by the addition of NaMP, then it is intracellular adhesion mediated
PIA-depended biofilm and if the strain is resistant to the added NaMP, then the biofilm
formation is PNAG independent [60]. We found that the msaB mutant and its wild type
and complement strains were resistant to NaMP and does not affect the biofilm formation
in the presence of NaMP (Figure 16).
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Figure 16. Effect of sodium metaperiodate on biofilm formation in msaB mutant, msaB
mutant complement, and wild type strains at different NaMP concentrations with 24 hrs
incubation (A), and at only one concentration of 20uM/ml, with different times intervals;
at 0 hour, 6 hrs, and 12 hrs (B); the standardized errors are represented as error bars.
Biofilms were exposed to DNase I (2U per well) at 6 hrs, and at 48 hrs of biofilm
development, the wells were washed and stained with crystal violet and the amount of
biofilm remaining was quantified at 595 nm. The addition of DNase I reduced the
biofilms in both wild and msaB mutant, thus indicating the importance of eDNA in the
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biofilm formation (Figure 17). Since there is no significant difference between the wild
type and the msaB deletion mutant, results of this study suggest that the eDNA is an
important component to the composition of biofilm; however, it is not responsible for
msaB mutant’s biofilm defect.
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Figure 17. Effect of DNaseI on biofilm formation in msaB mutant strain (Red bar),
compared to the LAC wild type (Blue bar) and msaB complement (Green bar) strains. It
shows decreased both wild and mutant strains after added DNase I (Test Group)
compared to control group (no DNase I was added).
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Addition of Proteinase K at any time point disrupted the biofilms in both wild and
msaB mutant strains, so we can concluded that both the wild type (LAC) and msaB
mutant strains were sensitive to DNaseI and proteinase K, and the protein and DNase I
are important in biofilm structure (Figure 18).
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Figure 18. Effect of Proteinase K on biofilm formation in msaB mutant strain (Red bar),
compared to the LAC wild type (Blue bar) and msaB complement (Green bar) strains. It
shows decreased both wild and mutant strains after added proteinase k enzyme (Test
Group) compared to control group (no proteinase K was added).
Discussion
For hundreds of years, scientists and dentists have been looking for efficient
methods to control oral diseases, since the oral ecosystem view has become more widely
accepted and oral bacterial interactions have been more elucidated [61]. Most infections
of the oral cavity, including the major dental diseases, caries and periodontitis, are
opportunistic in nature [62]. They are caused or maintained by microorganisms of the
resident or transient flora normally present in low numbers and not pathogenic, but in
certain circumstances develop infections.
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Mucosal infections have some degree of specificity (e.g., Candida spp.,
Staphylococcus aureus, and enterics), and a microbiological test can be interpreted
accurately for clinical diagnosis and choice of treatment. Sub-epithelial or deep infection
include a number of species from the resident flora, mainly anaerobes whose role in the
infections is difficult to interpret; however, microbiological tests for the presence of
certain bacterial species could be used for treatment control, risk-evaluation, and even for
patient motivation in the prevention of these diseases. Microbiological diagnosis can be
used in general practice for several purposes and in various situations that can be of great
value for the dental patient [63].
The occurrence of staphylococci in the oral cavity was examined using saliva and
supra-gingival plaque specimens from 56 systemically and periodentally healthy adults
aged 22-43 years old. Nine staphylococcus species and 334 isolates were identified, and
S. aureus was the most frequent species (46.4%), followed by staphylococcus
epidermidis (41.1%) and other species [64].
The ability of Staphylococcus spp and Candida spp to form a biofilm and live
within certain niches allows them to develop mechanisms that increase persistence, such
as the evasion of host defenses and antibiotic efficacy [12]. These microorganisms can
easily be or become resistant to antibiotics and lead to super infection. While the
diversity of organisms present in the oral cavity is well accepted, there remains
considerable controversy as to whether Staphylococcus spp. play a role in the ecology of
the normal oral flora [65].
Surprisingly, little detailed work has been done on the qualitative and quantitative
aspects of colonization or infection either by coagulase-negative staphylococci (CNS) or
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S. aureus [65]. The S. aureus is especially interesting in light of the present difficulty in
eradicating carriers of methicillin-resistant S. aureus (MRSA) from the oropharynx of the
affected individuals. Information on the risk of methicillin-resistant Staphylococcus
aureus (MRSA) infection transmission in dental healthcare settings was incomplete only
a few years ago; therefore, MRSA infection control guidelines were necessarily based on
data extrapolated from other fields. Recently, publication of specific studies has made it
possible to review such risk [66].
In this study we studied the role of the msaB gene, which is a part of msaABCR
operon that regulates biofilm development and other virulence factors in S. aureus. One
of the interesting findings is the important role of msaB in biofilm formation in the S.
aureus stains. Identification of the msaB will add insight into the complex network of
virulence regulation in S. aureus.
Despite the identification of numerous regulatory elements in S. aureus, it is still
unclear how this organism achieves the coordinated expression of virulence factors in the
host. It has been suggested that the unique regulation pattern of toxins and the biofilm
formation in these strains are primarily responsible for their increased virulence and
epidemic spread. Biofilm infections are extremely challenging to treat and the presence
of biofilms causes numerous problems in the field of medicine, interfering with clinical
therapeutics.
The environmental factors, such as glucose, osmolarity, ethanol, temperature, and
anaerobiosis, have been reported to affect biofilm formation [67]. Glucose has been
shown to induce the multicellular aggregation step of biofilm formation [68]. Osmotic
stress was found to induce biofilm formation [58]. Biofilm positive strains increased
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when grown under stress-induced conditions (NaCl, EthOH, sub-inhibitory levels of
tetracycline). However, induction of biofilm by NaCl is dependent on the concentration
of NaCl used [69]. Ethanol was shown to induce biofilm formation through icaR, which
represses the icaADBC genes [70]. IcaR was recently shown to bind to the promoter
region upstream of the icaA gene [71]. In contrast the effects of glucose and NaCl are not
mediated through icaR [70, 72]. Depending on the strain, ethanol at various
concentrations either positively or negatively regulates biofilm formation.
One of the key phenotypes of the msaB mutant is the decreased formation of the
biofilm formation. Indeed, there are several independent regulators and environmental
stimuli which contribute to establish sessile communities of S. aureus [73], although the
complete picture is still unclear and under investigation. COMSTAT analysis of confocal
microscopy of the biofilm formation by the msaB deletion mutant showed the presence of
significantly less live cell biomass by the mutant, 40% compared to 100% by the wild
type. The complement produced the cell biomass intermediate between the wild type and
complement. Moreover, the mutant showed the presence of increased cell death (169%)
compared to wild type (100%). This analysis suggests that increased number of cell death
might be responsible for the defective biofilm formation by the msaB mutant. Further
analysis by the COMSTAT also revealed that the mutant has significantly reduced
biofilm thickness (12 µm) compared to wild type (24 um).
In this study we have shown that msaB acts as a regulator of several genes that are
involved in protease production, virulence, and biofilm development. The msaB gene
encodes a 66-amino acid polypeptide that showed homology with cold-shock proteins of
E. coli (CspA, 60%) and Bacillus subtilis (CspB, 76%). Based on sequence homology, S.
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aureus produces three proteins (CspA, CspB, and CspC) that may be associated with
cold-shock stress [74, 75], however, Anderson et al., 2006 [76] showed that only CspB
responds to cold shock in S. aureus. This was confirmed by proteomic studies that
showed increased expression of CspB under cold shock, while CspA was not
differentially expressed.
Studies have also shown that the CspA transcript is more abundant than CspB and
CspC under normal growth conditions at 37°C, while the CspB predominates at 15°C
[76]. In addition, collective studies also have shown that the CspA is an important gene
for the cationic antimicrobial peptide of human lysosomal cathepsin G, and regulates
pigmentation in S. aureus through a sigB-dependent mechanism [74, 77]. This indicates
that CspA has biological functions other than the cold-shock response. In E. coli, the
CspA mRNA is a thermo sensor that modulates translation of the cold-shock protein
(CspA). The CspA mRNA in E. coli undergoes post-transcriptional modification in
response to environmental variations, such as a temperature shift from 37°C to 10°C [78,
79]. This RNA-dependent regulation of gene expression allows E. coli to rapidly adapt
and respond to its environment.
Further studies have shown that the CspA gene in E. coli produces a singlestranded nucleic acid-binding protein and an RNA chaperone. This protein is one of the
most abundant proteins during early growth phase, and its expression is even higher
during cold shock, accounting for 2% of the total proteins in the cell [80, 81]. Since msaB
(CspA) is not directly involved in cold shock in S. aureus, it is not clear if it has
maintained the same mechanism of regulation or functions as its homolog in E. coli. With
an increase in the number of S. aureus infections, clinicians may encounter additional
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complications such as antibiotics-resistance; therefore, understanding the virulence
mechanisms of this microorganism is warranted to establish adequate diagnosis and
provide proper treatment modalities.
Furthermore, we examined different environmental conditions that effect biofilm
formation on msaB mutant and compared them with msaB complement and the wild type
USA300_LAC. We first examined the effects of osmotic stress (NaCl), which was found
to induce biofilm formation in biofilm positive strains when grown under stress-induced
conditions [58]. We found that in the presence of different NaCl concentrations there is
no significant difference in the biofilm formation by the msaB mutant in any of the
concentrations of NaCl tested compared to its wild type and complement (Figure 13). We
also tested the effect of ethanol in combination with either NaCl or glucose in TSB. As
shown in Figure 14, the biofilm produced by the msaB deletion mutant is not
significantly different when grown in TSB/ethanol (Figure 14 A) and TSB/ethanol/NaCl
(Figure 14 C); however, interestingly msaB deletion mutant produced significantly
increased biofilm in TSB/ethanol/glucose (Figure 14 B). Further investigation is needed
to understand why msaB mutant produces more biofilm in TSB/ethanol/glucose.
Glucose has been shown to induce the multicellular aggregation step of biofilm
formation, which increases PIA production [59], and thus induces biofilm formation. We
found the defective biofilm formation by the msaB deletion mutant at low concentration
of glucose, whereas, as the concentration of glucose increases above 1%, the mutant
phenotype is restored in terms of biofilm formation back to wild type level. We still need
further explanation of and research on why msaB biofilm defect is glucose dependent,
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whereas the wild type and complement does not respond much to the change in glucose
concentration (Figure 15).
Conclusion
In conclusion, we defined the role of msaB gene, a part of a four-gene operon,
msaABCR, that regulates virulence and biofilm development in S. aureus. We studied the
role of msaB gene in regulating important global regulators of virulence genes like sarA
and agr. We also studied its role in pathogenesis in terms of protease activity, autolysis,
pigmentation, and biofilm formation. The msaB gene showed decreased pigmentation,
increased protease activity, increased cell death, and reduced biofilm formation.
These findings suggest that msaB is also an important gene in the msaABCR
operon that regulates other global regulators and virulence in S. aureus. Further research
is needed to address the mechanism of regulation of this operon and its interaction with
its target genes.

	
  

44	
  
REFERENCES
1.

Kluytmans J, van Belkum A, Verbrugh H: Nasal carriage of Staphylococcus
aureus: epidemiology, underlying mechanisms, and associated risks. Clinical
microbiology reviews 1997, 10(3):505-520.

2.

Cole AM, Tahk S, Oren A, Yoshioka D, Kim YH, Park A, Ganz T: Determinants
of Staphylococcus aureus nasal carriage. Clinical and diagnostic laboratory
immunology 2001, 8(6):1064-1069.

3.

Borrell C, Rue M, M IP, Benach J, A EK: [The measurement of inequalities in
health]. Gaceta sanitaria / SESPAS 2000, 14(Suppl 3):20-33.

4.

Noble M: Communications in the National Health Service—a survey of some
of the published research findings. International journal of nursing studies
1967, 4(1):15-28.

5.

Cooke EM, Casewell MW, Emmerson AM, Gaston M, de Saxe M, Mayon-White
RT, Galbraith NS: Methicillin-resistant Staphylococcus aureus in the UK and
Ireland. A questionnaire survey. Journal of hospital infection 1986, 8(2):143148.

6.

Daniell WE, Fulton-Kehoe D, Cohen M, Swan SS, Franklin GM: Increased
reporting of occupational hearing loss: workers' compensation in
Washington State, 1984-1998. American journal of industrial medicine 2002,
42(6):502-510.

7.

Sanches IS, Ramirez M, Troni H, Abecassis M, Padua M, Tomasz A, de
Lencastre H: Evidence for the geographic spread of a methicillin-resistant
Staphylococcus aureus clone between Portugal and Spain. Journal of clinical
microbiology 1995, 33(5):1243-1246.

8.

Dominguez MA, de Lencastre H, Linares J, Tomasz A: Spread and maintenance
of a dominant methicillin-resistant Staphylococcus aureus (MRSA) clone
during an outbreak of MRSA disease in a Spanish hospital. Journal of clinical
microbiology 1994, 32(9):2081-2087.

	
  

45	
  
9.

Li X, Kolltveit KM, Tronstad L, Olsen I: Systemic diseases caused by oral
infection. Clinical microbiology reviews 2000, 13(4):547-558.

10.

Marsh PD, Percival RS: The oral microflora—friend or foe? Can we decide?
International dental journal 2006, 56(4 Suppl 1):233-239.

11.

Shao ZY, Tang ZS, Yan C, Jiang YT, Ma R, Liu Z, Huang ZW: Effects of
intensity-modulated radiotherapy on human oral microflora. Journal of
radiation research 2011, 52(6):834-839.

12.

Cuesta AI, Jewtuchowicz V, Brusca MI, Nastri ML, Rosa AC: Prevalence of
Staphylococcus spp and Candida spp in the oral cavity and periodontal
pockets of periodontal disease patients. Acta odontologica latinoamericana:
AOL 2010, 23(1):20-26.

13.

Passariello C, Puttini M, Iebba V, Pera P, Gigola P: Influence of oral conditions
on colonization by highly toxigenic Staphylococcus aureus strains. Oral
diseases 2012, 18(4):402-409.

14.

Groom AV, Wolsey DH, Naimi TS, Smith K, Johnson S, Boxrud D, Moore KA,
Cheek JE: Community-acquired methicillin-resistant Staphylococcus aureus
in a rural American Indian community. JAMA: the journal of the American
Medical Association 2001, 286(10):1201-1205.

15.

Spratt DA, Latif J, Montebugnoli LL, Wilson M: In vitro modeling of dental
water line contamination and decontamination. FEMS microbiology letters
2004, 235(2):363-367.

16.

Foster T: Staphylococcus. In Medical Microbiology. 4th edited. by Baron S.
Galveston (TX); Medical Microbiology 1996, ISBN-10: 0-9631172-1-1

17.

Park B, Iwase T, Liu GY: Intranasal application of S. epidermidis prevents
colonization by methicillin-resistant Staphylococcus aureus in mice. PloS one
2011, 6(10):e25880.

18.

Wilson M: Bacterial biofilms and human disease. Science progress 2001, 84(Pt
3):235-254.

	
  

46	
  
19.

Lei MG, Cue D, Alba J, Junecko J, Graham JW, Lee CY: A single copy
integration vector that integrates at an engineered site on the Staphylococcus
aureus chromosome. BMC research notes 2012, 5:5 doi:10.1186/1756-0500-5-5.

20.

Shaw LN, Lindholm C, Prajsnar TK, Miller HK, Brown MC, Golonka E, Stewart
GC, Tarkowski A, Potempa J: Identification and characterization of sigma, a
novel component of the Staphylococcus aureus stress and virulence
responses. PloS one 2008, 3(12):e3844.

21.

Kiedrowski MR, Kavanaugh JS, Malone CL, Mootz JM, Voyich JM, Smeltzer
MS, Bayles KW, Horswill AR: Nuclease modulates biofilm formation in
community-associated methicillin-resistant Staphylococcus aureus. PloS one
2011, 6(11):e26714.

22.

Ahn SJ, Ahn SJ, Wen ZT, Brady LJ, Burne RA: Characteristics of biofilm
formation by Streptococcus mutans in the presence of saliva. Infection and
immunity 2008, 76(9):4259-4268.

23.

Ehrlich GD, Stoodley P, Kathju S, Zhao Y, McLeod BR, Balaban N, Hu FZ,
Sotereanos NG, Costerton JW, Stewart PS et al. Engineering approaches for the
detection and control of orthopaedic biofilm infections. Clinical orthopaedics
and related research 2005, (437):59-66.

24.

Teitzel GM, Parsek MR: Heavy metal resistance of biofilm and planktonic
Pseudomonas aeruginosa. Applied and environmental microbiology 2003,
69(4):2313-2320.

25.

Davey ME, O'Toole GA: Microbial biofilms: from ecology to molecular
genetics. Microbiology and molecular biology reviews: MMBR 2000, 64(4):847867.

26.

Suci PA, Mittelman MW, Yu FP, Geesey GG: Investigation of ciprofloxacin
penetration into Pseudomonas aeruginosa biofilms. Antimicrobial agents and
chemotherapy 1994, 38(9):2125-2133.

27.

Karatan E, Watnick P: Signals, regulatory networks, and materials that build
and break bacterial biofilms. Microbiology and molecular biology reviews:
MMBR 2009, 73(2):310-347.

	
  

47	
  
28.

Boles BR, Singh PK: Endogenous oxidative stress produces diversity and
adaptability in biofilm communities. Proceedings of the National Academy of
Sciences of the United States of America 2008, 105(34):12503-12508.

29.

Molin S, Tolker-Nielsen T: Gene transfer occurs with enhanced efficiency in
biofilms and induces enhanced stabilisation of the biofilm structure. Current
opinion in biotechnology 2003, 14(3):255-261.

30.

Kuroda M, Ohta T, Uchiyama I, Baba T, Yuzawa H, Kobayashi I, Cui L, Oguchi
A, Aoki K, Nagai Y et al: Whole genome sequencing of meticillin-resistant
Staphylococcus aureus. Lancet 2001, 357(9264):1225-1240.

31.

Peng HL, Novick RP, Kreiswirth B, Kornblum J, Schlievert P: Cloning,
characterization, and sequencing of an accessory gene regulator (agr) in
Staphylococcus aureus. Journal of bacteriology 1988, 170(9):4365-4372.

32.

Falord M, Mader U, Hiron A, Debarbouille M, Msadek T: Investigation of the
Staphylococcus aureus GraSR regulon reveals novel links to virulence, stress
response and cell wall signal transduction pathways. PloS one 2011,
6(7):e21323.

33.

Rigoulay C, Entenza JM, Halpern D, Widmer E, Moreillon P, Poquet I, Gruss A:
Comparative analysis of the roles of HtrA-like surface proteases in two
virulent Staphylococcus aureus strains. Infection and immunity 2005,
73(1):563-572.

34.

Chien Y, Manna AC, Projan SJ, Cheung AL: SarA, a global regulator of
virulence determinants in Staphylococcus aureus, binds to a conserved motif
essential for sar-dependent gene regulation. Journal of biological chemistry
1999, 274(52):37169-37176.

35.

Gordon CP, Williams P, Chan WC: Attenuating Staphylococcus aureus
virulence gene regulation: a medicinal chemistry perspective. Journal of
medicinal chemistry 2013, 56(4):1389-1404.

36.

Beenken KE, Blevins JS, Smeltzer MS: Mutation of sarA in Staphylococcus
aureus limits biofilm formation. Infection and immunity 2003, 71(7):4206-4211.

	
  

48	
  
37.

Beenken KE, Mrak LN, Griffin LM, Zielinska AK, Shaw LN, Rice KC, Horswill
AR, Bayles KW, Smeltzer MS: Epistatic relationships between sarA and agr
in Staphylococcus aureus biofilm formation. PloS one 2010, 5(5):e10790.

38.

Cassat J, Dunman PM, Murphy E, Projan SJ, Beenken KE, Palm KJ, Yang SJ,
Rice KC, Bayles KW, Smeltzer MS: Transcriptional profiling of a
Staphylococcus aureus clinical isolate and its isogenic agr and sarA mutants
reveals global differences in comparison to the laboratory strain RN6390.
Microbiology 2006, 152(Pt 10):3075-3090.

39.

Boles BR, Horswill AR: Agr-mediated dispersal of Staphylococcus aureus
biofilms. PLoS pathogens 2008, 4(4):e1000052.

40.

Sun Q, Smith GM, Zahradka C, McGavin MJ: Identification of D motif epitopes
in Staphylococcus aureus fibronectin-binding protein for the production of
antibody inhibitors of fibronectin binding. Infection and immunity 1997,
65(2):537-543.

41.

Yarwood JM, Bartels DJ, Volper EM, Greenberg EP: Quorum sensing in
Staphylococcus aureus biofilms. Journal of bacteriology 2004, 186(6):18381850.

42.

Janzon L, Hanson BS, Isacsson SO, Lindell SE, Steen B: Factors influencing
participation in health surveys. Results from prospective population study
'Men born in 1914' in Malmo, Sweden. Journal of epidemiology and community
health 1986, 40(2):174-177.

43.

Gertz S, Engelmann S, Schmid R, Ziebandt AK, Tischer K, Scharf C, Hacker J,
Hecker M: Characterization of the sigma(B) regulon in Staphylococcus
aureus. Journal of bacteriology 2000, 182(24):6983-6991.

44.

Palma M, Cheung AL: sigma(B) activity in Staphylococcus aureus is
controlled by RsbU and an additional factor(s) during bacterial growth.
Infection and immunity 2001, 69(12):7858-7865.

45.

Deora R, Tseng T, Misra TK: Alternative transcription factor sigma B of
Staphylococcus aureus: characterization and role in transcription of the
global regulatory locus sar. Journal of bacteriology 1997, 179(20):6355-6359.

	
  

49	
  
46.

Horsburgh MJ, Aish JL, White IJ, Shaw L, Lithgow JK, Foster SJ: sigmaB
modulates virulence determinant expression and stress resistance:
characterization of a functional rsbU strain derived from Staphylococcus
aureus 8325-4. Journal of bacteriology 2002, 184(19):5457-5467.

47.

Bischoff M, Dunman P, Kormanec J, Macapagal D, Murphy E, Mounts W,
Berger-Bachi B, Projan S: Microarray-based analysis of the Staphylococcus
aureus sigmaB regulon. Journal of bacteriology 2004, 186(13):4085-4099.

48.

Sahukhal GS, Elasri MO: Identification and characterization of an operon,
msaABCR, that controls virulence and biofilm development in
Staphylococcus aureus. BMC microbiology 2014, 14(1):154.

49.

Hebraud M, Potier P: Cold shock response and low temperature adaptation in
psychrotrophic bacteria. Journal of molecular microbiology and biotechnology
1999, 1(2):211-219.

50.

Ermolenko DN, Makhatadze GI: Bacterial cold-shock proteins. Cellular and
molecular life sciences: CMLS 2002, 59(11):1902-1913.

51.

Stuyt RJ, Kim SH, Reznikov LL, Fantuzzi G, Novick D, Rubinstein M, Kullberg
BJ, van der Meer JW, Dinarello CA, Netea MG: Regulation of Staphylococcus
epidermidis-induced IFN-gamma in whole human blood: the role of
endogenous IL-18, IL-12, IL-1, and TNF. Cytokine 2003, 21(2):65-73.

52.

Nagarajan V, Elasri MO: SAMMD: Staphylococcus aureus microarray metadatabase. BMC genomics 2007, 8:351.

53.

Manna C, Galletti P, Cucciolla V, Moltedo O, Leone A, Zappia V: The
protective effect of the olive oil polyphenol (3,4-dihydroxyphenyl)-ethanol
counteracts reactive oxygen metabolite-induced cytotoxicity in Caco-2 cells.
Journal of nutrition 1997, 127(2):286-292.

54.

Morikawa K, Maruyama A, Inose Y, Higashide M, Hayashi H, Ohta T:
Overexpression of sigma factor, sigma(B), urges Staphylococcus aureus to
thicken the cell wall and to resist beta-lactams. Biochemical and biophysical
research communications 2001, 288(2):385-389.

	
  

50	
  
55.

Sambanthamoorthy K, Smeltzer MS, Elasri MO: Identification and
characterization of msa (SA1233), a gene involved in expression of SarA and
several virulence factors in Staphylococcus aureus. Microbiology 2006, 152(Pt
9):2559-2572.

56.

Sambanthamoorthy K, Schwartz A, Nagarajan V, Elasri MO: The Role of msa in
Staphylococcus aureus Biofilm Formation. BMC microbiology 2008, 8:221.

57.

Rice KC, Mann EE, Endres JL, Weiss EC, Cassat JE, Smeltzer MS, Bayles KW:
The cidA murein hydrolase regulator contributes to DNA release and biofilm
development in Staphylococcus aureus. Proceedings of the National Academy
of Sciences of the United States of America 2007, 104(19):8113-8118.

58.

Rachid S, Cho S, Ohlsen K, Hacker J, Ziebuhr W: Induction of Staphylococcus
epidermidis biofilm formation by environmental factors: the possible
involvement of the alternative transcription factor sigB. Advances in
experimental medicine and biology 2000, 485:159-166.

59.

Cramton SE, Gerke C, Gotz F: In vitro methods to study staphylococcal
biofilm formation. Methods in enzymology 2001, 336:239-255.

60.

Wang X, Preston JF, III, Romeo T: The pgaABCD locus of Escherichia coli
promotes the synthesis of a polysaccharide adhesin required for biofilm
formation. Journal of bacteriology 2004, 186(9):2724-2734.

61.

Huang R, Li M, Gregory RL: Bacterial interactions in dental biofilm. Virulence
2011, 2(5):435-444.

62.

Ruby J, Barbeau J: Le puzzle buccale: La nature symbiotique des infections
endogènes de la cavité buccale (The buccale puzzle: The symbiotic nature of
endogenous infections of the oral cavity). (The Canadian journal of infectious
diseases) Journal canadien des maladies infectieuses 2002, 13(1):34-41.

63.

Dahlen G: Microbiological diagnostics in oral diseases. Acta odontologica
Scandinavica 2006, 64(3):164-168.

	
  

51	
  
64.

Ohara-Nemoto Y, Ono T, Shimoyama Y, Kimura S, Nemoto TK: Homologous
and heterologous expression and maturation processing of extracellular
glutamyl endopeptidase of Staphylococcus epidermidis. Biological chemistry
2008, 389(9):1209-1217.

65.

Smith AJ, Jackson MS, Bagg J: The ecology of Staphylococcus species in the
oral cavity. Journal of medical microbiology 2001, 50(11):940-946.

66.

Petti S, Polimeni A: Risk of methicillin-resistant Staphylococcus aureus
transmission in the dental healthcare setting: a narrative review. Infection
control and hospital epidemiology: the official journal of the Society of Hospital
Epidemiologists of America 2011, 32(11):1109-1115.

67.

Gotz F: Staphylococcus and biofilms. Molecular microbiology 2002,
43(6):1367-1378.

68.

You Y, Xue T, Cao L, Zhao L, Sun H, Sun B: Staphylococcus aureus glucoseinduced biofilm accessory proteins, GbaAB, influence biofilm formation in a
PIA-dependent manner. International journal of medical microbiology: IJMM
2014.

69.

Fitzpatrick F, Humphreys H, O'Gara JP: Environmental regulation of biofilm
development in methicillin-resistant and methicillin-susceptible
Staphylococcus aureus clinical isolates. Journal of hospital infection 2006,
62(1):120-122.

70.

Conlon KM, Humphreys H, O'Gara JP: icaR encodes a transcriptional
repressor involved in environmental regulation of ica operon expression and
biofilm formation in Staphylococcus epidermidis. Journal of bacteriology
2002, 184(16):4400-4408.

71.

Jefferson KK, Cramton SE, Gotz F, Pier GB: Identification of a 5-nucleotide
sequence that controls expression of the ica locus in Staphylococcus aureus
and characterization of the DNA-binding properties of IcaR. Molecular
microbiology 2003, 48(4):889-899.

72.

Dobinsky S, Kiel K, Rohde H, Bartscht K, Knobloch JK, Horstkotte MA, Mack
D: Glucose-related dissociation between icaADBC transcription and biofilm

	
  

52	
  
expression by Staphylococcus epidermidis: evidence for an additional factor
required for polysaccharide intercellular adhesin synthesis. Journal of
bacteriology 2003, 185(9):2879-2886.
73.

McCann MT, Gilmore BF, Gorman SP: Staphylococcus epidermidis devicerelated infections: pathogenesis and clinical management. Journal of
pharmacy and pharmacology 2008, 60(12):1551-1571.

74.

Katzif S, Danavall D, Bowers S, Balthazar JT, Shafer WM: The major cold
shock gene, cspA, is involved in the susceptibility of Staphylococcus aureus to
an antimicrobial peptide of human cathepsin G. Infection and immunity 2003,
71(8):4304-4312.

75.

Chanda PK, Bandhu A, Jana B, Mondal R, Ganguly T, Sau K, Lee CY,
Chakrabarti G, Sau S: Characterization of an unusual cold shock protein from
Staphylococcus aureus. Journal of basic microbiology 2010, 50(6):519-526.

76.

Anderson KL, Roberts C, Disz T, Vonstein V, Hwang K, Overbeek R, Olson PD,
Projan SJ, Dunman PM: Characterization of the Staphylococcus aureus heat
shock, cold shock, stringent, and SOS responses and their effects on logphase mRNA turnover. Journal of bacteriology 2006, 188(19):6739-6756.

77.

Katzif S, Lee EH, Law AB, Tzeng YL, Shafer WM: CspA regulates pigment
production in Staphylococcus aureus through a SigB-dependent mechanism.
Journal of bacteriology 2005, 187(23):8181-8184.

78.

Brandi A, Pietroni P, Gualerzi CO, Pon CL: Post-transcriptional regulation of
CspA expression in Escherichia coli. Molecular microbiology 1996, 19(2):231240.

79.

Giuliodori AM, Di Pietro F, Marzi S, Masquida B, Wagner R, Romby P, Gualerzi
CO, Pon CL: The cspA mRNA is a thermosensor that modulates translation
of the cold-shock protein CspA. Molecular cell 2010, 37(1):21-33.

80.

Goldstein J, Pollitt NS, Inouye M: Major cold shock protein of Escherichia
coli. Proceedings of the National Academy of Sciences of the United States of
America 1990, 87(1):283-287.

	
  

53	
  
81.

	
  

Jiang W, Hou Y, Inouye M: CspA, the major cold-shock protein of
Escherichia coli, is an RNA chaperone. Journal of biological chemistry 1997,
272(1):196-202.

